Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KRT77 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HIF3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINC00607 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCG18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCAT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COIL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKN2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSM11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JMJD1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFT2D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FHAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIPAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSG7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYRF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on